Clonal T-cell-mediated erythroid failure: redefining pure red cell aplasia across the T-cell large granular lymphocytic leukemia spectrum
Year: 2026
Type: article
Abstract: Pure red cell aplasia (PRCA) is a clinically important manifestation of T-cell large granular lymphocytic leukemia (T-LGLL), yet severe erythroid failure may occur when the circulating clone is small and conventional leukemic thresholds are not met. We review evidence suggesting possible biological links among reactive cytotoxic T-cell expansion, T-cell clones of uncertain significance, low-burden clonal disease, and overt T-LGLL, with PRCA highlighting the clinical significance of clonal T-cell pathogenicity. STAT3/JAK-STAT activation, apoptosis resistance, cytotoxic effector programs, antigen-driven T-cell receptor selection, marrow inflammation, and host clonal hematopoiesis provide complementary mechanisms. Causal attribution should integrate confirmed PRCA, exclusion of competing causes, immunophenotypic and T-cell receptor clonality, and appropriately interpreted molecular findings. Cyclosporine and cyclophosphamide remain central therapies; methotrexate is phenotype-dependent, whereas sirolimus and JAK inhibition are rational options for refractory disease. Future studies should prioritize clone-resolved multi-omics, standardized response endpoints, and prospective molecularly stratified registries. This framework prioritizes pathogenicity over numerical clone burden.
Source: Frontiers in Immunology
Authors: Jingwen Qin(Conceptualization, Writing – original draft, Writing – review & editing), Fangting Wang(Conceptualization, Investigation, Writing – review & editing), Jiawen Yu(Methodology, Project administration, Writing – original draft), Yanyu Zhang(Conceptualization, Formal analysis, Investigation, Methodology, Project administration, Validation, Writing – original draft)
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,801
OpenAlex ID: W7234939318
